FDA Status
Under ReviewUnder Active FDA Review
A synthetic antioxidant used to prevent fats and oils from going rancid. Listed as reasonably anticipated to be a human carcinogen by the US National Toxicology Program.
Concerns
- •classified as reasonably anticipated to be a human carcinogen by NTP
- •endocrine disruption observed in animal studies
- •stomach and liver tumors in animal studies
CAERS Adverse Events
No adverse event reports found.
CAERS data is voluntary. Reports indicate correlation, not causation. About CAERS
International Status
European Union
restrictedCanada
restrictedCommonly Found In
cerealschewing gumsnack foodsbutterdehydrated potatoesbeer
Find products containing BHA
Search 2.8M+ products in our database.